Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.21.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Revenue:        
Total revenue $ 516 $ 0 $ 12,566 $ 0
Operating expenses:        
Cost of product revenues 145 0 145 0
Research and development 4,401 8,030 16,083 26,364
Selling, general and administrative 15,411 3,481 34,879 9,448
Total operating expenses 19,957 11,511 51,107 35,812
Loss from operations (19,441) (11,511) (38,541) (35,812)
Other expense (income):        
Loss on extinguishment of debt 0 0 2,725 806
Amortization of debt issuance costs and discount 413 311 937 910
Interest income (8) (5) (20) (188)
Interest expense 1,019 330 1,678 859
Other income 0 0 0 (386)
Other expense 0 20 0 602
Warrant liabilities fair value adjustment (18,810) (7,786) (35,378) (16,114)
Derivative liabilities fair value adjustment (1,400) (5,290) (1,772) (6,683)
Total other income (18,786) (12,420) (31,830) (20,194)
(Loss) income before taxes (655) 909 (6,711) (15,618)
Income tax benefit (50) 0 (3,088) (3,144)
Net (loss) income $ (605) $ 909 $ (3,623) $ (12,474)
Net (loss) income per share attributable to common stockholders – basic        
Net (loss) income per share – basic $ (0.02) $ 0.09 $ (0.14) $ (1.23)
Net loss per share attributable to common stockholders – diluted        
Net loss per share – diluted $ (0.06) $ (0.28) $ (0.73) $ (1.37)
Weighted average common shares outstanding – basic and diluted        
Basic 26,616,628 10,627,618 26,147,658 10,129,098
Diluted 27,754,828 13,389,014 26,326,006 11,220,802
Product Revenue, Net        
Revenue:        
Total revenue $ 516 $ 0 $ 516 $ 0
License Agreement Revenue        
Revenue:        
Total revenue $ 0 $ 0 $ 12,050 $ 0